A Study of the Alternative Administration of Ixabepilone and Vinflunine

Completed · Phase 1

Conditions studied: Cancer

In brief

The purpose of the study is to test how vinflunine interacts with ixabepilone in the human body.

Key facts

Study ID

NCT00362830

Run by

Bristol-Myers Squibb

People needed

60

Starts

2006-08-01

Expected to finish

2007-09-01

Last updated by the study team

2016-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ECOG status of 0-1

You may not qualify if…

• Inability to tolerate venous access
• Brain mets
• Severe nerve damage
• ANC <2,000/mm3
• Platelets <100K
• Bilirubin >= 1.5 times the IULN
• ALT/AST >= 2.5 times the IULN
• Creatinine <50 mL/min
• Prior treatment with vinflunine and/or ixabepilone
• Strong use of CYPP450 drugs

Where it is running

• University Of Miami Miller School Of Medicine — Miami, Florida, United States
• The Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.